EUCTR2005-004809-29-IT进行中（未招募）不适用
The steady state pharmacokinetics (PK) of atazanavir boosted with ritonavir during pregnancy and postpartum in HIV-1 infected pregnant women
AZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO (A.O. DI RILIEVO NAZIONALE)0 个研究点开始时间: 2007年9月12日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Pilotstudy to asses the pharmacokinetics, the efficacy and safety of the combination of atazanavir, dolutegravir and lamivudine in HIV-1 infected patients who experience side-effects, toxicities or resistance to other anti-HIV drugs.HIVMedDRA version: 17.1Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 100000004862EUCTR2014-004488-19-NLRadboud University Medical Center20
进行中（未招募）
1 期
Pharmacocinétique de l’atazanavir chez des patients infectés par le VIH, traités en première ligne par l’association atazanavir+ritonavir et emtricitabine+ténofovir en prise unique. - COPHAR-3EUCTR2007-003203-12-FRAgence nationale de recherches sur le sida et les hépatites virales. ANRS
进行中（未招募）
不适用
Pharmacokinetics of atazanavir at the dose of 300mg or 400mg in subjects with HIV-1 infection and non-decompensated hepatic cirrhosis (Child-Pugh A o B, Metavir F4), crossover study. - EPAZANAVIR-1EUCTR2007-005330-37-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)
已完成
不适用
Prediction of the pharmacokinetics of asunaprevir in patients with hepatitis C virus by gadoxetic-acid-enhanced-magnetic resonance imagingType C chronic hepatitis or type C liver cirrhosisJPRN-UMIN000016667Juntendo University Nerima Hospital Department of Gastroenterology90
进行中（未招募）
不适用
A Study to Look at the Way the Body Absorbs and Distributes Posaconazole in the Blood and Lungs of Lung Transplant Recipients (PAPAL Study)Invasive fungal infection (IFI) in lung transplant patients with and without cystic fibrosis.MedDRA version: 15.0Level: PTClassification code 10049085Term: Antifungal prophylaxisSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2012-003140-68-GBMSD40